Weesp, Netherlands

Michiel H De Vries

This inventor holds 1 USPTO granted patent. Top assignee: Solvay Pharmaceuticals, B.v.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michiel H De Vries. Retrieved from https://idiyas.com/inventor/michiel-h-de-vries

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michiel H De Vries: Innovator in Pharmaceutical Dosage Forms

Introduction

Michiel H De Vries is a notable inventor based in CP Weesp, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel dosage forms. His work focuses on improving treatment methods for various diseases and disorders.

Latest Patents

One of his key patents is titled "Bifeprunox mesylate maintenance dose compositions and methods for using the same." This patent presents innovative pharmaceutical dosage forms designed for maintenance treatment doses. The methods outlined in this patent aim to treat and prevent diseases and disorders effectively.

Career Highlights

Michiel is associated with Solvay Pharmaceuticals B.V., where he has been instrumental in advancing pharmaceutical research and development. His expertise in dosage forms has contributed to the company's reputation for innovation in the pharmaceutical industry.

Collaborations

Throughout his career, Michiel has collaborated with several professionals, including Irene Eijgendaal and Gerrit Klein. These collaborations have fostered a productive environment for research and development in the pharmaceutical sector.

Conclusion

In summary, Michiel H De Vries is a distinguished inventor whose work in pharmaceutical dosage forms has the potential to enhance treatment options for various health conditions. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…